Back
ESC Premium Access

PEARL, a non-interventional study on real-world use of alirocumab in German clinical practice: final study and cardiovascular subgroup data

Session: Poster Session 6 - Preventive cardiology / Lipids
Topic: Drug therapy
Speaker: Professor K. Parhofer (Munich, DE)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Professor Klaus G Parhofer

Ludwig Maximilians University, Munich (Germany)
4 presentations
0 follower

20 more presentations in this session

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Speaker: Doctor I. Dykun (Essen, DE)

Access
Abstract
Like
Thumbnail

Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

Speaker: Doctor D. Huber (Umea, SE)

Access
Abstract
Slides
Like
Thumbnail

Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients

Speaker: Doctor Y. Kumada (Kasamatsu, JP)

Access
Abstract
Like
Thumbnail

The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris

Speaker: Doctor G. Svingen (Bergen, NO)

Access
Abstract
Like
Thumbnail

Post-prandial remnant lipoprotein metabolism in sitosterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 6 - Preventive cardiology / Lipids

Speakers: Professor K. Parhofer, Doctor I. Dykun, Doctor D. Huber, Doctor Y. Kumada, Doctor G. Svingen...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources